Status:
UNKNOWN
IMP3 and PCNA Expression in Laryngeal Squamous Cell Carcinoma in Sohag Governorate
Lead Sponsor:
Sohag University
Conditions:
Laryngeal Squamous Cell Carcinoma
Eligibility:
All Genders
Brief Summary
Laryngeal cancer is responsible for 2-5% of all new cancer cases worldwide. Squamous cell carcinoma of the larynx (LSCC) is the most common malignant tumor of the larynx, accounting for 85-90% of all ...
Eligibility Criteria
Inclusion
- Laryngeal resection (total or partial laryngectomy) and biopsies.
- Complete clinical data.
Exclusion
- Patients with recurrence of the primary tumor.
- Patients with a history of preoperative chemotherapy and/or radiotherapy.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05293327
Start Date
June 1 2022
End Date
June 1 2023
Last Update
April 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Sohag University
Sohag, Egypt, 82511